| Dr Marshall L Stoller, MD | |
|
400 Parnassus Ave # A633, San Francisco, CA 94143-2202 | |
| (415) 353-2200 | |
| (415) 353-2480 |
| Full Name | Dr Marshall L Stoller |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 43 Years |
| Location | 400 Parnassus Ave # A633, San Francisco, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104854512 | NPI | - | NPPES |
| 00A388980 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | A38898 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Marinhealth Medical Center | Greenbrae, CA | Hospital |
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ucsf Medical Group Business Services | 3779497870 | 1064 |
| University Of California Sfgh Medical Group | 5496668410 | 488 |
News Archive
Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.
Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionize breast screening by allowing it to be tailored to women at minimal extra cost.
› Verified 9 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.
Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionize breast screening by allowing it to be tailored to women at minimal extra cost.
› Verified 9 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.
Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionize breast screening by allowing it to be tailored to women at minimal extra cost.
› Verified 9 days ago
| Entity Name | University Of California Sfgh Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407821465 PECOS PAC ID: 5496668410 Enrollment ID: O20050328001098 |
News Archive
Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.
Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionize breast screening by allowing it to be tailored to women at minimal extra cost.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marshall L Stoller, MD 1635 Divisadero St, Suite 625, Box 1821, San Francisco, CA 94143-0001 Ph: () - | Dr Marshall L Stoller, MD 400 Parnassus Ave # A633, San Francisco, CA 94143-2202 Ph: (415) 353-2200 |
News Archive
Recent technological developments in genomics have revealed a large number of genetic influences on common complex diseases, such as diabetes, asthma, cancer or schizophrenia. However, discovering a genetic variant predisposing to a disease is only a first step. To apply this knowledge towards prevention or cure, including tailoring treatment to the patient's genetic profile -also known as personalized medicine - we need to know how this genetic variant affects health.
Integrated Diagnostics launched officially today with more than $30 million in funding. A pre-eminent team of scientists and investors are behind the company, which was founded by renowned biotechnology innovator Dr. Leroy Hood. Integrated Diagnostics will focus on developing personalized and preventive diagnostics based on breakthroughs using genomic and proteomic technologies to identify organ-specific proteins.
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments.
Senator John Kerry (D-Mass.), chairman of the Senate Foreign Relations Committee, and ranking member, Senator Richard Lugar (R-Ind.), on Tuesday "introduced a bill to overhaul the U.S. system for providing global development aid," the Boston Globe reports (Smith, 7/29). The legislation was also introduced by Senators Robert Menendez (D-NJ) and Bob Corker (R-Tenn.), according to a release from Menendez's office (7/28).
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionize breast screening by allowing it to be tailored to women at minimal extra cost.
› Verified 9 days ago
Dr. Wenwu Jin, M.D., PH.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 929 Clay St, Suite 505, San Francisco, CA 94108 Phone: 415-392-9690 Fax: 415-392-9695 | |
Raymond Fay, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 929 Clay St, #505, San Francisco, CA 94108 Phone: 415-392-9690 Fax: 415-392-9695 | |
Christi Butler, Urology Medicare: Accepting Medicare Assignments Practice Location: 400 Parnassus Avenue, 6th Floor, A610, San Francisco, CA 94143 Phone: 628-206-8000 | |
Mayra Lucas Ramirez, Urology Medicare: Not Enrolled in Medicare Practice Location: 400 Parnassus Ave # A633, San Francisco, CA 94143 Phone: 310-825-6373 | |
Dr. Antonio Otero, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 450 6th Ave, 4th Floor - Urology, San Francisco, CA 94118 Phone: 415-833-3239 Fax: 415-833-2563 | |
Dr. Kevin Shee, MD, PHD Urology Medicare: Medicare Enrolled Practice Location: 400 Parnassus Ave # A610, San Francisco, CA 94143 Phone: 415-885-3690 | |
Justin Ahn, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 400 Parnassus Ave, # A610, San Francisco, CA 94143 Phone: 415-885-7748 |